- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Swissray delivers on big contract
X-ray vendor Swissray International of Hitzkirch, Switzerland has begun the first deliveries on a $40 million contract to supply bucky-table x-ray systems to Philips Medical Systems of Best, the Netherlands. Swissray is supplying Philips with its Bucky
X-ray vendor Swissray International of Hitzkirch, Switzerland has begun the first deliveries on a $40 million contract to supply bucky-table x-ray systems to Philips Medical Systems of Best, the Netherlands. Swissray is supplying Philips with its Bucky Diagnost TS system, which Philips is distributing worldwide under its own label.
Swissray announced last year that it had landed a $40 million order for conventional x-ray systems from a major medical imaging OEM (SCAN 7/17/96), but waited until last week to identify its partner as Philips. The companies expect to sell as many as 500 Bucky Diagnost TS systems a year, for a total value of $40 million over the next four years.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
December 9th 2024In research involving over 2,200 women who had SPECT MPI exams, researchers found that those who had a high score with the COronary Risk Score in WOmen (CORSWO) model had a greater than fourfold higher risk of major adverse coronary events (MACE).
